PepGen Inc (PEPG) Tezkor likvidlik
PepGen Inc. (PEPG) uchun narxlar tendentsiyasi 13.32 qiymatini aks ettirmoqda. Biznes mushak patologiyalari uchun terapiya vositalarini ishlab chiqishga e'tibor qaratadi, bunda tadqiqot va ishlanmalar xarajatlari operatsion samaradorlikni salbiy hududda ushlab turibdi. Jamoa innovatsion loyihalar va aksiyalar opsion dasturlari bilan jalb qilingan yetakchi genetikalardan iborat. Yuqori maoshlar va akademik erkinlik kompaniyaga neuromuskulyar davolash vositalarini ishlab chiquvchi birinchi darajali bioximiklarni saqlab qolishga yordam beradi.
PepGen Inc. (PEPG) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati PepGen Inc.|PEPG - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati pepgen.com|PEPG - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati PepGen Corp|PEPG - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli majburiyatlari PepGen|Tezkor likvidlik koeffitsiyenti pepgen.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:PepGen Inc.
Ushbu ko'rsatkich past likvidlikka ega bo'lgan zaxiralarni hisobga olmagan holda, naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarni qoplash qobiliyatini o'lchash orqali operatsion barqarorlikni aks ettiradi. Neuromuskulyar patologiya dori vositalari uchun qimmatbaho klinik sinovlarga e'tibor qaratgan PepGen Inc. (PEPG) uchun ushbu metrika moliyaviy avtonomiyani baholashda muhim ahamiyatga ega bo'lib, tezkor likvidlik tendentsiyasini aniq namoyish etadi.
Muhim raqobatchilar
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|Tezkor likvidlik Regencell Bioscience|axsome.com - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ACAD|XENE - Shoshilinch likvidlik|Tezkor likvidlik Viking Pharma VKTX|SUPN (Supernus Corp) - Kritik likvidlik koeffitsiyenti|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik denalitherapeutics.com (DNLI)|HRMY: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Biohaven Ltd (BHVN)|Tezkor likvidlik Amylyx|Shoshilinch likvidlik koeffitsiyenti TRVI (Trevi Corp)|Tezkor likvidlik ko‘rsatkichi PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CBLL (CeriBell)|Oraliq qoplama koeffitsiyenti Prothena Corp (PRTA)|ALEC - Tezkor likvidlik|ANNX (Annexon Biosciences Inc.) - Shoshilinch likvidlik koeffitsiyenti|OMER: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi neurogene.com|Tezkor likvidlik ko‘rsatkichi ACIU|Voyager Therapeutics Inc (VYGR) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Neumora Therapeutics Inc (NMRA)|SCLX: Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|Alpha Cognition Inc (ACOG) - Shoshilinch likvidlik|CGTX - Tezkor likvidlik|Kritik likvidlik koeffitsiyenti IKT|SAVA: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Assertio ASRT|Tezkor likvidlik Coya Therapeutics Inc|Shoshilinch likvidlik koeffitsiyenti VTGN (VistaGen Therapeutics Inc)|Tezkor likvidlik koeffitsiyenti OVID|ABOS - Shoshilinch likvidlik|CervoMed Inc - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Alterity Therapeutics Ltd. ATHE|CLNN - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti JUNS (Jupiter Neurosciences, Inc.)|Relmada Therapeutics, Inc. (RLMD) - Tezkor likvidlik|Shoshilinch likvidlik Annovis Bio Inc (ANVS)|Tezkor likvidlik Grace Therapeutics Inc|Firefly Neuro - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti KLTO|NRSN - Shoshilinch likvidlik|Tezkor likvidlik Reviva Pharmaceuticals Holdings, Inc. RVPH|MTVA (MetaVia Inc.) - Kritik likvidlik koeffitsiyenti|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Helius Medical (HSDT)|PASG: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|Tezkor likvidlik Minerva Neurosciences, Inc.|Shoshilinch likvidlik koeffitsiyenti ATHA (Athira Pharma Inc)|Tezkor likvidlik ko‘rsatkichi ADXN (Addex Therapeutics, Ltd.)|ALZN (alzamend.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti CYCN (Cyclerion Therapeutics, Inc.)|Oraliq qoplama koeffitsiyenti Protagenic Therapeutics Inc. (PTIX)|KTTA - Tezkor likvidlik|CRGT (Cortigent, Inc.) - Shoshilinch likvidlik koeffitsiyenti|ATXI: Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi BrainStorm Cell Therapeutics Inc.|Tezkor likvidlik ko‘rsatkichi CARA|chromocell.com (CHRO) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|ITCI: Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti LBPH (Longboard Pharma)|Marinus Pharma (MRNS) - Shoshilinch likvidlik|NKGN - Tezkor likvidlik|Kritik likvidlik koeffitsiyenti NRBO|SAGE: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Synaptogenix Inc. SNPX|Tezkor likvidlik Trevena, Inc|Shoshilinch likvidlik koeffitsiyenti VIGL (Vigil Neuro)|Tezkor likvidlik koeffitsiyenti WENA|CERE - Shoshilinch likvidlik